https://simplecast.com Embracing the Challenge - Advancing Cancer Care The Private Cancer Physician’s Association (PCPA) is an oncology specialist organisation that aims to make high impact policy change for private practice, education and in delivering to patients the latest treatments and world-class clinical trials. The Cancer Patient Management Podcast series shares the latest updates in innovation for oncology specialists and the ecosystem in which they work to deliver best practice care for their patients. The information in this podcast is current at the time of recording, however we can’t guarantee that it will always apply to you. Be aware that you should seek your own medical advice from your doctor or health professional within your own locality. Music Take My Time by Sun Tones Produced by SciencetoLife Private Cancer Physicians of Australia and Music Take My Time by Sun Tones en Fri, 18 Apr 2025 01:00:00 +0000 Fri, 18 Apr 2025 01:00:13 +0000 https://embracing-the-challenge-advancing-cancer-care.simplecast.com Embracing the Challenge - Advancing Cancer Care https://image.simplecastcdn.com/images/34c98a02-d00d-4ef3-ab9d-b638d7f51fc4/0d261dbf-5726-4849-9352-8b047b673673/3000x3000/channelgraphic-patientmanagement.jpg?aid=rss_feed https://embracing-the-challenge-advancing-cancer-care.simplecast.com episodic The Private Cancer Physician’s Association (PCPA) is an oncology specialist organisation that aims to make high impact policy change for private practice, education and in delivering to patients the latest treatments and world-class clinical trials. The Cancer Patient Management Podcast series shares the latest updates in innovation for oncology specialists and the ecosystem in which they work to deliver best practice care for their patients. The information in this podcast is current at the time of recording, however we can’t guarantee that it will always apply to you. Be aware that you should seek your own medical advice from your doctor or health professional within your own locality. Music Take My Time by Sun Tones Produced by SciencetoLife Private Cancer Physicians of Australia false https://feeds.simplecast.com/8xXa05MV cancer, cancer physicians, oncology, patient care Rose Brown team@sciencetolife.com.au 30a2e222-f3a8-4e33-8514-359b13797fe3 Urothelial Carcinoma and Emerging ADCs Fri, 18 Apr 2025 01:00:00 +0000 team@sciencetolife.com.au (Dr Tony Michele, Dr Elizabeth Liow, Dr Laurence Krieger) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/urothelial-carcinoma-and-emerging-adcs-qQjmSt_q Urothelial Carcinoma and Emerging ADCs Dr Tony Michele, Dr Elizabeth Liow, Dr Laurence Krieger 00:00:56 In our latest podcast we discuss urothelial carcinoma and the latest advances in treating with antibody drug conjugates (ADCs), as a new therapeutic option. Dr Tony Michele, Medical Oncologist from Adelaide Oncology and Haematology, part of the Genesiscare Group, and PCPA Board member is joined by Dr Elizabeth Liow, Medical Oncologist at Monash in Melbourne and Dr Laurence Krieger, Medical Oncologist at Genesis Care North Shore Hub in Sydney. Our podcasters deep experience in managing these patients is invaluable in this transforming field of expertise. https://www.pcpa.org.au/ In our latest podcast we discuss urothelial carcinoma and the latest advances in treating with antibody drug conjugates (ADCs), as a new therapeutic option. Dr Tony Michele, Medical Oncologist from Adelaide Oncology and Haematology, part of the Genesiscare Group, and PCPA Board member is joined by Dr Elizabeth Liow, Medical Oncologist at Monash in Melbourne and Dr Laurence Krieger, Medical Oncologist at Genesis Care North Shore Hub in Sydney. Our podcasters deep experience in managing these patients is invaluable in this transforming field of expertise. https://www.pcpa.org.au/ adcs, urothelial cancer, private cancer physicians of australia, antibody-drug conjugates, pcpa, bladder cancer, private cancer physicians australia false full 9 498d49e9-484c-48ba-91cd-7c1768d844ac CAR T-cell Therapy in Australia: Paradigm Changing Technology Tue, 28 May 2024 02:00:00 +0000 team@sciencetolife.com.au (Dr Ian Irving, Associate Professor Mary Ann Anderson, Dr Allison Barraclough) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/car-t-cell-therapy-in-australia-paradigm-changing-technology-ZeDGakHF CAR T-cell Therapy in Australia: Paradigm Changing Technology Dr Ian Irving, Associate Professor Mary Ann Anderson, Dr Allison Barraclough 00:32:38 In this PCPA Podcast Dr Ian Irving, PCPA Board Member, Haematologist and Chief Medical Officer at ICON Group, discusses CAR T-cell therapy, a transformative approach reshaping the landscape of haematologic malignancies. CAR T-cell therapy leverages a patient's own immune system to target and eradicate cancer cells with remarkable precision. Throughout this episode, we delve into the mechanisms of action, clinical trial data, and practical considerations for integrating CAR T-cell therapy into your practice. Ian is joined by Associate Professor Mary Ann Anderson, Haematologist from the Peter MacCallum Cancer Centre in Melbourne and Dr Allison Barraclough, Haematologist from the Fiona Stanley Hospital in Perth. In this PCPA Podcast Dr Ian Irving, PCPA Board Member, Haematologist and Chief Medical Officer at ICON Group, discusses CAR T-cell therapy, a transformative approach reshaping the landscape of haematologic malignancies. CAR T-cell therapy leverages a patient's own immune system to target and eradicate cancer cells with remarkable precision. Throughout this episode, we delve into the mechanisms of action, clinical trial data, and practical considerations for integrating CAR T-cell therapy into your practice. Ian is joined by Associate Professor Mary Ann Anderson, Haematologist from the Peter MacCallum Cancer Centre in Melbourne and Dr Allison Barraclough, Haematologist from the Fiona Stanley Hospital in Perth. car t-cell, haematology, haematological, car t false full 8 18ed544b-b1d1-4993-b008-d93921faedb5 Leadership Stories: Women in Oncology Research Thu, 7 Mar 2024 00:50:07 +0000 team@sciencetolife.com.au (fran boyle, victoria atkinson, amy davies) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/leadership-stories-women-in-oncology-research-_vTAweWp Leadership Stories: Women in Oncology Research fran boyle, victoria atkinson, amy davies 00:32:50 In this PCPA Podcast we focus on Leadership Stories: Women in Oncology Research, launched on International Women’s Day 2024. Professor Fran Boyle, Medical Oncologists and Supportive care Physician from the Mater Hospital in Sydney discusses the unique challenges and opportunities with Professor Victoria Atkinson from Greenslopes Private Hospital and the Princess Alexandra Hospital in Brisbane and also Dr Amy Davies, Medical Oncologist and Research Scientist from Victoria. We tackle: Is it necessary to go overseas to progress your career? Can you do great research in the private sector? What are the special qualities and strengths women bring to cancer care? This episode is a powerful tribute to the remarkable women who are shaping the future of cancer research and making a significant impact on the lives of thousands of cancer patients. It's a reminder of the importance of diversity and inclusion in scientific research and the crucial role women play in driving innovation and progress. In this PCPA Podcast we focus on Leadership Stories: Women in Oncology Research, launched on International Women’s Day 2024. Professor Fran Boyle, Medical Oncologists and Supportive care Physician from the Mater Hospital in Sydney discusses the unique challenges and opportunities with Professor Victoria Atkinson from Greenslopes Private Hospital and the Princess Alexandra Hospital in Brisbane and also Dr Amy Davies, Medical Oncologist and Research Scientist from Victoria. We tackle: Is it necessary to go overseas to progress your career? Can you do great research in the private sector? What are the special qualities and strengths women bring to cancer care? This episode is a powerful tribute to the remarkable women who are shaping the future of cancer research and making a significant impact on the lives of thousands of cancer patients. It's a reminder of the importance of diversity and inclusion in scientific research and the crucial role women play in driving innovation and progress. internation womens day, women in oncology, cancer research, iwd false full 7 2e92d5d7-545b-45d2-9f1d-c27fcfd3ddb4 The What, When, Why and How of IDH Mutations in Cancer Mon, 29 Jan 2024 04:00:00 +0000 team@sciencetolife.com.au (Shehara Mendis, Michael Rodriguez, Daniel Thomas) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/the-what-when-why-and-how-of-idh-mutations-in-cancer-LzYTumlC The What, When, Why and How of IDH Mutations in Cancer Shehara Mendis, Michael Rodriguez, Daniel Thomas 00:28:43 In this PCPA podcast we discuss The What, When, Why and How of IDH Mutations in Cancer? The discussion covers the understanding of IDH mutations in cancer, a completely new enzyme driving cancer in both solid tumours and in haematology. Experts are on hand to cover the nuances in molecular testing and review current and future therapies and trends in these patient populations. Dr Shehara Mendis, Medical Oncologist from Cabrini Hospital in Melbourne chairs this discussion with Dr Michael Rodriguez, Consultant Neuropathologist, St Vincent's Hospital and POW Hospital Sydney; Douglass Hanly Moir Pathology and Associate Professor Daniel Thomas, a Clinical Haematologist and Cancer Scientist from the University of Adelaide. In this PCPA podcast we discuss The What, When, Why and How of IDH Mutations in Cancer? The discussion covers the understanding of IDH mutations in cancer, a completely new enzyme driving cancer in both solid tumours and in haematology. Experts are on hand to cover the nuances in molecular testing and review current and future therapies and trends in these patient populations. Dr Shehara Mendis, Medical Oncologist from Cabrini Hospital in Melbourne chairs this discussion with Dr Michael Rodriguez, Consultant Neuropathologist, St Vincent's Hospital and POW Hospital Sydney; Douglass Hanly Moir Pathology and Associate Professor Daniel Thomas, a Clinical Haematologist and Cancer Scientist from the University of Adelaide. haematology, solid tumours, idh, pcpa, idh mutations, enzyme driving cancer, molecular testing, private cancer physicians australia false full 6 171d33bb-9384-4f8f-afb7-595de603e87a Most Patients With Cancer are Older - How Does this Impact their Care? Sun, 17 Dec 2023 19:49:30 +0000 team@sciencetolife.com.au (Etienne Brain, Christopher Steer) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/most-patients-with-cancer-are-older-how-does-this-impact-their-care-8jn1yOnW Most Patients With Cancer are Older - How Does this Impact their Care? Etienne Brain, Christopher Steer 00:23:52 In this PCPA podcast we discuss “Most Patients With Cancer are Older - How Does this Impact their Care?” The conversation explores this specialised field which focuses on the care of older adults with cancer. Since more than 50% of patients will be over 65 years of age in the next few years and as an oncologist treating older patients with cancer, it's crucial to understand the unique challenges and considerations involved in their care . A/Professor Christopher Steer , medical oncologist from Albury/Wodonga and President of the Private Cancer Physicians of Australia is joined by Dr Etienne Brain, MD, PhD, senior medical oncologist at Institut Curie, in Saint-Cloud, France, who was honoured with the 2022 B.J. Kennedy Geriatric Oncology Award for his career-long contributions to advancing clinical research in breast cancer in older populations. In this PCPA podcast we discuss “Most Patients With Cancer are Older - How Does this Impact their Care?” The conversation explores this specialised field which focuses on the care of older adults with cancer. Since more than 50% of patients will be over 65 years of age in the next few years and as an oncologist treating older patients with cancer, it's crucial to understand the unique challenges and considerations involved in their care . A/Professor Christopher Steer , medical oncologist from Albury/Wodonga and President of the Private Cancer Physicians of Australia is joined by Dr Etienne Brain, MD, PhD, senior medical oncologist at Institut Curie, in Saint-Cloud, France, who was honoured with the 2022 B.J. Kennedy Geriatric Oncology Award for his career-long contributions to advancing clinical research in breast cancer in older populations. false full 5 b6713c05-83c2-42ee-8b49-e17ec9c7e134 Voluntary Assisted Dying: What you need to know Mon, 18 Sep 2023 02:00:00 +0000 team@sciencetolife.com.au (Laurie Draper, Hilda High, Cameron McLaren, Private Cancer Physicians of Australia) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/voluntary-assisted-dying-what-you-need-to-know-rivsZT51 Voluntary Assisted Dying: What you need to know Laurie Draper, Hilda High, Cameron McLaren, Private Cancer Physicians of Australia 00:36:36 Dr Cameron McLaren, Medical Oncologists and PCPA Board Member from Victoria is joined by Laurie Draper, a voluntary assisted dying care navigator from the State-wide Care Service in Melbourne and Dr Hilda High Medical Oncologist specialising in Cancer Genetics from Sydney. In this Private Cancer Physician of Australia podcast they discuss voluntary assisted dying and what you need to know as a health care professional to manage the change in care. With the impending changes around the country regarding voluntary assisted dying Dr Hilda High asks pertinent questions for health professionals to Cam and Laurie to draw on their experience with their program in Victoria. https://www.gogentleaustralia.org.au/conference_2023 - VAD National Conference 2023 https://cesphn.org.au/news/voluntary-dying-conference - NSW VAD Implementation Conference 2023 Dr Cameron McLaren, Medical Oncologists and PCPA Board Member from Victoria is joined by Laurie Draper, a voluntary assisted dying care navigator from the State-wide Care Service in Melbourne and Dr Hilda High Medical Oncologist specialising in Cancer Genetics from Sydney. In this Private Cancer Physician of Australia podcast they discuss voluntary assisted dying and what you need to know as a health care professional to manage the change in care. With the impending changes around the country regarding voluntary assisted dying Dr Hilda High asks pertinent questions for health professionals to Cam and Laurie to draw on their experience with their program in Victoria. https://www.gogentleaustralia.org.au/conference_2023 - VAD National Conference 2023 https://cesphn.org.au/news/voluntary-dying-conference - NSW VAD Implementation Conference 2023 voluntary assisted dying, private cancer physicians of australia, vad, pcpa false full 4 025f01c6-7bfe-4ee5-a04c-e32361637f9d Precision Medicine for Australian Patients with Cancer Wed, 28 Jun 2023 00:30:00 +0000 team@sciencetolife.com.au (Desmond Yip, Lorraine Chantrill, Vivek Rathi) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/precision-medicine-for-australian-patients-with-cancer-Sl1jdXgv Precision Medicine for Australian Patients with Cancer Desmond Yip, Lorraine Chantrill, Vivek Rathi 00:28:05 Molecular profiling plays a crucial role in optimizing cancer care by enabling personalized treatment decisions, improving treatment outcomes, and offering potential avenues for targeted therapies and clinical trial participation. In this PCPA Podcast, Professor Desmond Yip, PCPA Secretary and Treasurer and Senior Staff Specialist in Medical Oncology at the Canberra Hospital is joined by Professor Lorraine Chantrill, Senior Staff Specialist Medical Oncologist and Head of Service for Medical Oncology across the Illawarra Shoalhaven Local Health District (ISLHD), and Area Clinical Director of Clinical Trials and also Dr Vivek Rathi, Director of Operations, Group Medical Director, Group Molecular Pathologist at LifeStrands Genomics. In this podcast, they discuss precision medicine for Australian patients with cancer, current genetic pathology and actionable targets. We look to the future of comprehensive genomic profiling (CGP) and how to make this a clinical solution for all. The PCPA is a dynamic, not-for-profit Oncology specialist organisation that aims to improve the care of cancer patients in the private health system, believing that cancer care should be the best it can be for our patients, their families and our members who are entrusted to care for them. Molecular profiling plays a crucial role in optimizing cancer care by enabling personalized treatment decisions, improving treatment outcomes, and offering potential avenues for targeted therapies and clinical trial participation. In this PCPA Podcast, Professor Desmond Yip, PCPA Secretary and Treasurer and Senior Staff Specialist in Medical Oncology at the Canberra Hospital is joined by Professor Lorraine Chantrill, Senior Staff Specialist Medical Oncologist and Head of Service for Medical Oncology across the Illawarra Shoalhaven Local Health District (ISLHD), and Area Clinical Director of Clinical Trials and also Dr Vivek Rathi, Director of Operations, Group Medical Director, Group Molecular Pathologist at LifeStrands Genomics. In this podcast, they discuss precision medicine for Australian patients with cancer, current genetic pathology and actionable targets. We look to the future of comprehensive genomic profiling (CGP) and how to make this a clinical solution for all. The PCPA is a dynamic, not-for-profit Oncology specialist organisation that aims to improve the care of cancer patients in the private health system, believing that cancer care should be the best it can be for our patients, their families and our members who are entrusted to care for them. cancer, cancer patients, cgp, pcpa, precision medicine, private cancer physicians australia false full 3 ebc3659b-7441-46fa-b34f-4333853822e7 Antibody-Drug Conjugates: Transforming Breast Cancer Treatment Wed, 24 May 2023 01:50:00 +0000 team@sciencetolife.com.au (Hope Rugo, Belinda Yeo, Richard de Boer) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/antibody-drug-conjugates-transforming-breast-cancer-treatment-sN1W30_s Antibody-Drug Conjugates: Transforming Breast Cancer Treatment Hope Rugo, Belinda Yeo, Richard de Boer 00:22:57 The Private Cancer Physician’s Podcast series on Managing Patients with Cancer is pleased to release its new podcast: Antibody-Drug Conjugates: Transforming Breast Cancer Treatment In this podcast, we discuss antibody-drug conjugates (ADCs) and the transformative role they are playing in the fight against metastatic breast cancer. ADCs are “smart bombs” that provide a new construct to treat metastatic breast cancer, with higher efficacy and less off target toxicities. Dr Richard de Boer, Medical Oncologist from the Peter MacCallum Cancer Centre is joined by Professor Hope Rugo, Director, Breast Oncology and Clinical Trials Education and Medical Director of Cancer Infusion Services, UCSF as well as Dr Belinda Yeo, Medical Oncologist from the Austin Hospital in Melbourne, Australia, and Clinician Scientist from the Olivia Newton-John Cancer Research Institute. Produced by ScienceToLife The Private Cancer Physician’s Podcast series on Managing Patients with Cancer is pleased to release its new podcast: Antibody-Drug Conjugates: Transforming Breast Cancer Treatment In this podcast, we discuss antibody-drug conjugates (ADCs) and the transformative role they are playing in the fight against metastatic breast cancer. ADCs are “smart bombs” that provide a new construct to treat metastatic breast cancer, with higher efficacy and less off target toxicities. Dr Richard de Boer, Medical Oncologist from the Peter MacCallum Cancer Centre is joined by Professor Hope Rugo, Director, Breast Oncology and Clinical Trials Education and Medical Director of Cancer Infusion Services, UCSF as well as Dr Belinda Yeo, Medical Oncologist from the Austin Hospital in Melbourne, Australia, and Clinician Scientist from the Olivia Newton-John Cancer Research Institute. Produced by ScienceToLife breast cancer treatment, private cancer physicians of australia, antibody-drug conjugates, metastatic breast cancer, breast cancer, pcpa, adc, breast cancer management false full 2 04d15f65-36d5-4ce8-a679-8eb1f53db20c The Patient Doctor Music:  Take My Time by The Sun Tones

Produced by SciencetoLife

]]> Fri, 24 Feb 2023 00:40:00 +0000 team@sciencetolife.com.au (Ben Bravery, Cameron McLaren, Katrin Sjoquist, Christopher Steer) https://embracing-the-challenge-advancing-cancer-care.simplecast.com/episodes/the-patient-doctor-OlZsuojq Music:  Take My Time by The Sun Tones

Produced by SciencetoLife

]]> The Patient Doctor Ben Bravery, Cameron McLaren, Katrin Sjoquist, Christopher Steer 00:29:55 What happens when a Doctor can experience the health system through patient eyes? Dr Ben Bravery, author of the Patient Doctor and a Registrar in Sydney, Australia, tells his story of being diagnosed with Stage III colorectal cancer and enabling change from within the health system. In discussion are our PCPA leads, Dr Cameron McLaren, Medical Oncologist at Monash Health and St John of God Melbourne Australia and A/Prof Katrin Sjoquist, Medical Oncologist at St George Private Hospital and Clinical Lead at the NHMRC Clinical Trials Centre, we explore how a patient becomes the centrepoint for the core of healthcare decisions. What happens when a Doctor can experience the health system through patient eyes? Dr Ben Bravery, author of the Patient Doctor and a Registrar in Sydney, Australia, tells his story of being diagnosed with Stage III colorectal cancer and enabling change from within the health system. In discussion are our PCPA leads, Dr Cameron McLaren, Medical Oncologist at Monash Health and St John of God Melbourne Australia and A/Prof Katrin Sjoquist, Medical Oncologist at St George Private Hospital and Clinical Lead at the NHMRC Clinical Trials Centre, we explore how a patient becomes the centrepoint for the core of healthcare decisions. colorectal cancer, patient doctor, cancer patient, patient advocate, pcpa false full 1